IL142063A0 - Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same - Google Patents
Tetrahydropyridoether derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL142063A0 IL142063A0 IL14206399A IL14206399A IL142063A0 IL 142063 A0 IL142063 A0 IL 142063A0 IL 14206399 A IL14206399 A IL 14206399A IL 14206399 A IL14206399 A IL 14206399A IL 142063 A0 IL142063 A0 IL 142063A0
- Authority
- IL
- Israel
- Prior art keywords
- tetrahydropyridoether
- derivatives
- same
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843504 | 1998-09-23 | ||
EP98117988 | 1998-09-23 | ||
PCT/EP1999/006899 WO2000017200A1 (en) | 1998-09-23 | 1999-09-17 | Tetrahydropyridoethers |
Publications (1)
Publication Number | Publication Date |
---|---|
IL142063A0 true IL142063A0 (en) | 2002-03-10 |
Family
ID=26049024
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14206399A IL142063A0 (en) | 1998-09-23 | 1999-09-17 | Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same |
IL142063A IL142063A (en) | 1998-09-23 | 2001-03-18 | History of 10,9,8,7 – Tetrahydro-9 – Phenyl – 8,7,3,2 – Transformed Tetra – Imidazo [2,1–H] [7,1] Neptyridine and pharmaceutical preparations containing them |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL142063A IL142063A (en) | 1998-09-23 | 2001-03-18 | History of 10,9,8,7 – Tetrahydro-9 – Phenyl – 8,7,3,2 – Transformed Tetra – Imidazo [2,1–H] [7,1] Neptyridine and pharmaceutical preparations containing them |
Country Status (31)
Country | Link |
---|---|
US (4) | US6436953B1 (hu) |
EP (1) | EP1115725B1 (hu) |
JP (1) | JP4145492B2 (hu) |
KR (1) | KR100668400B1 (hu) |
CN (2) | CN1155598C (hu) |
AT (1) | ATE231862T1 (hu) |
AU (1) | AU763463B2 (hu) |
BG (1) | BG65195B1 (hu) |
BR (1) | BR9914044A (hu) |
CA (1) | CA2344251A1 (hu) |
CZ (1) | CZ292335B6 (hu) |
DE (1) | DE69905178T2 (hu) |
DK (1) | DK1115725T3 (hu) |
EA (1) | EA005377B1 (hu) |
EE (1) | EE04677B1 (hu) |
ES (1) | ES2191464T3 (hu) |
GE (1) | GEP20032926B (hu) |
HK (1) | HK1038360B (hu) |
HR (1) | HRP20010224A2 (hu) |
HU (1) | HUP0102990A3 (hu) |
ID (1) | ID28896A (hu) |
IL (2) | IL142063A0 (hu) |
NO (1) | NO317304B1 (hu) |
NZ (1) | NZ510610A (hu) |
PL (1) | PL193616B1 (hu) |
PT (1) | PT1115725E (hu) |
RS (1) | RS50145B (hu) |
SI (1) | SI1115725T1 (hu) |
SK (1) | SK285165B6 (hu) |
TR (1) | TR200100805T2 (hu) |
WO (1) | WO2000017200A1 (hu) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4145492B2 (ja) | 1998-09-23 | 2008-09-03 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | テトラヒドロピリドエーテル |
US6503923B1 (en) | 1999-04-17 | 2003-01-07 | Altana Pharma Ag | Haloalkoxy imidazonaphthyridines |
CA2285516C (en) * | 1999-05-12 | 2010-12-07 | President And Fellows Of Harvard College | Dopamine transporter imaging agents |
ATE311389T1 (de) * | 2000-03-29 | 2005-12-15 | Altana Pharma Ag | Wirkstoffvorläufer von imidazopyridin-derivaten |
KR100823761B1 (ko) * | 2000-03-29 | 2008-04-21 | 니코메드 게엠베하 | 트리시클릭 이미다조피리딘 |
JP2004512338A (ja) * | 2000-10-25 | 2004-04-22 | アルタナ ファルマ アクチエンゲゼルシャフト | 胃液分泌抑制剤としてのポリ置換イミダゾピリジン |
UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
WO2002069968A1 (en) * | 2001-03-08 | 2002-09-12 | Astrazeneca Ab | New use |
ATE336493T1 (de) | 2001-08-02 | 2006-09-15 | Altana Pharma Ag | Tricyclische epoxide |
PL368586A1 (en) * | 2001-08-03 | 2005-04-04 | Altana Pharma Ag | Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders |
US20040235882A1 (en) * | 2001-08-03 | 2004-11-25 | Jorg Senn-Bilfinger | Amino-substituted imidazopyridines for the treatment of gastrointestial diseases |
JP2005519933A (ja) | 2002-02-15 | 2005-07-07 | アルタナ ファルマ アクチエンゲゼルシャフト | 三環式n−アシル化合物 |
MY140561A (en) * | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
CN1652822A (zh) * | 2002-05-07 | 2005-08-10 | 奥坦纳医药公司 | 用于治疗气道病症的可逆质子泵抑制剂和气道治疗剂的新组合 |
US7326718B2 (en) | 2002-11-19 | 2008-02-05 | Altana Pharma Ag | 8-Substituted imidazopyridines |
ATE405275T1 (de) | 2002-12-12 | 2008-09-15 | Nycomed Gmbh | Kombinationsarzneimittel aus r,r-formoterol und ciclesonide |
EP1585516A2 (en) * | 2002-12-20 | 2005-10-19 | ALTANA Pharma AG | 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines |
EP1599175A2 (en) * | 2003-02-17 | 2005-11-30 | ALTANA Pharma AG | Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
EP1606261B1 (en) | 2003-03-10 | 2009-11-04 | Nycomed GmbH | Novel process for the preparation of roflumilast |
TW200503783A (en) * | 2003-04-11 | 2005-02-01 | Altana Pharma Ag | Oral pharmaceutical preparation for proton pump antagonists |
SA04250092B1 (ar) * | 2003-05-14 | 2008-05-04 | التانا فاروا ايه جي | مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً |
US20060241134A1 (en) * | 2003-05-27 | 2006-10-26 | Altana Pharma Ga | Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility |
EP1663313A2 (en) * | 2003-08-29 | 2006-06-07 | Dynogen Pharmaceuticals Inc. | Compositions useful for treating gastrointestinal motility disorders |
EP1670482B2 (en) | 2003-09-16 | 2022-06-29 | Covis Pharma B.V. | Use of ciclesonide for the treatment of respiratory diseases |
CN1874772A (zh) | 2003-11-03 | 2006-12-06 | 阿斯利康(瑞典)有限公司 | 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物 |
US7326784B2 (en) | 2003-12-19 | 2008-02-05 | Altana Pharma Ag | Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives |
AR047605A1 (es) * | 2004-02-17 | 2006-01-25 | Altana Pharma Ag | Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos. |
PT1784404E (pt) | 2004-09-03 | 2011-12-09 | Yuhan Corp | Derivados de pirrolo[2,3-c]piridina e processos para a sua preparação |
RU2397170C2 (ru) | 2004-09-03 | 2010-08-20 | Юхан Корпорейшн | ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-b]ПИРИДИНА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ |
KR100946219B1 (ko) | 2004-09-03 | 2010-03-08 | 주식회사유한양행 | 피롤로[3,2-c]피리딘 유도체 및 그의 제조방법 |
CA2601250C (en) * | 2005-03-16 | 2014-10-28 | Nycomed Gmbh | Taste masked dosage form containing roflumilast |
EP2080513A1 (en) * | 2008-01-16 | 2009-07-22 | Schraermeyer, Ulrich, Prof. Dr. rer. nat | Tetrahydropyridoethers for treatment of AMD |
US8648080B2 (en) | 2009-07-09 | 2014-02-11 | Raqualia Pharma Inc. | Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility |
WO2012027240A1 (en) * | 2010-08-23 | 2012-03-01 | Schering Corporation | Fused tricyclic inhibitors of mammalian target of rapamycin |
BR112014031396B1 (pt) * | 2012-06-15 | 2019-11-26 | Bio Pharm Solutions Co Ltd | composto de sulfamato de fenilalquila e composição de relaxante muscular compreendendo o mesmo |
WO2015052256A1 (en) | 2013-10-08 | 2015-04-16 | Katairo Gmbh | Tetrahydropyridoethers for the treatment of stargardt's disease |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4468400A (en) * | 1982-12-20 | 1984-08-28 | Schering Corporation | Antiulcer tricyclic imidazo [1,2-a]pyridines |
ATE145907T1 (de) * | 1987-07-16 | 1996-12-15 | Byk Gulden Lomberg Chem Fab | Imidazo(1,2-a>pyridine |
SE9401197D0 (sv) * | 1994-04-11 | 1994-04-11 | Astra Ab | Active compounds |
JPH10505332A (ja) * | 1994-07-28 | 1998-05-26 | ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング | アシルイミダゾピリジン |
EE03771B1 (et) * | 1997-03-24 | 2002-06-17 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine |
WO1998042707A1 (en) * | 1997-03-24 | 1998-10-01 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahydropyrido compounds |
JP4145492B2 (ja) * | 1998-09-23 | 2008-09-03 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | テトラヒドロピリドエーテル |
-
1999
- 1999-09-17 JP JP2000574109A patent/JP4145492B2/ja not_active Expired - Lifetime
- 1999-09-17 SI SI9930207T patent/SI1115725T1/xx unknown
- 1999-09-17 WO PCT/EP1999/006899 patent/WO2000017200A1/en active IP Right Grant
- 1999-09-17 EA EA200100315A patent/EA005377B1/ru not_active IP Right Cessation
- 1999-09-17 KR KR1020017003553A patent/KR100668400B1/ko not_active IP Right Cessation
- 1999-09-17 PL PL99346617A patent/PL193616B1/pl not_active IP Right Cessation
- 1999-09-17 RS YUP-214/01A patent/RS50145B/sr unknown
- 1999-09-17 CZ CZ20011082A patent/CZ292335B6/cs not_active IP Right Cessation
- 1999-09-17 CN CNB998112992A patent/CN1155598C/zh not_active Expired - Fee Related
- 1999-09-17 IL IL14206399A patent/IL142063A0/xx active IP Right Grant
- 1999-09-17 AT AT99948776T patent/ATE231862T1/de not_active IP Right Cessation
- 1999-09-17 PT PT99948776T patent/PT1115725E/pt unknown
- 1999-09-17 CN CNB2004100384351A patent/CN100506821C/zh not_active Expired - Fee Related
- 1999-09-17 NZ NZ510610A patent/NZ510610A/en unknown
- 1999-09-17 TR TR2001/00805T patent/TR200100805T2/xx unknown
- 1999-09-17 DK DK99948776T patent/DK1115725T3/da active
- 1999-09-17 BR BR9914044-6A patent/BR9914044A/pt not_active Application Discontinuation
- 1999-09-17 EE EEP200100172A patent/EE04677B1/xx not_active IP Right Cessation
- 1999-09-17 CA CA002344251A patent/CA2344251A1/en not_active Abandoned
- 1999-09-17 HU HU0102990A patent/HUP0102990A3/hu unknown
- 1999-09-17 ID IDW20010682A patent/ID28896A/id unknown
- 1999-09-17 DE DE69905178T patent/DE69905178T2/de not_active Expired - Lifetime
- 1999-09-17 EP EP99948776A patent/EP1115725B1/en not_active Expired - Lifetime
- 1999-09-17 US US09/582,212 patent/US6436953B1/en not_active Expired - Lifetime
- 1999-09-17 SK SK399-2001A patent/SK285165B6/sk not_active IP Right Cessation
- 1999-09-17 GE GEAP19995786A patent/GEP20032926B/en unknown
- 1999-09-17 AU AU61920/99A patent/AU763463B2/en not_active Expired
- 1999-09-17 ES ES99948776T patent/ES2191464T3/es not_active Expired - Lifetime
-
2001
- 2001-02-19 BG BG105270A patent/BG65195B1/bg unknown
- 2001-03-12 NO NO20011243A patent/NO317304B1/no not_active IP Right Cessation
- 2001-03-18 IL IL142063A patent/IL142063A/en not_active IP Right Cessation
- 2001-03-23 HR HR20010224A patent/HRP20010224A2/hr not_active Application Discontinuation
-
2002
- 2002-01-03 HK HK02100042.6A patent/HK1038360B/zh not_active IP Right Cessation
- 2002-03-25 US US10/103,733 patent/US6696460B2/en not_active Expired - Lifetime
-
2004
- 2004-02-23 US US10/783,512 patent/US7105676B2/en not_active Expired - Lifetime
-
2006
- 2006-07-27 US US11/493,707 patent/US7393860B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL142063A0 (en) | Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same | |
HUP0200450A3 (en) | Cephen derivatives containing an imidazo[4,5-b]pyridiniummethyl moiety, process for their preparation and pharmaceutical compositions of the same | |
HUP0104204A3 (en) | Pyrazolopyridine derivatives as cox-2 inhibitors, process for their preparation and pharmaceutical compositions thereof | |
AU2001230892A1 (en) | Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same | |
HUP0203142A3 (en) | Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
HK1031869A1 (en) | 1-Ä(1-Substituted-4-piperidinyl)methylÜ-4-piperdine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds. | |
HUP0102313A3 (en) | Imidazo pyridine derivatives, process for their preparation pharmaceutical compositions containing the same and intermediates | |
HUP0101813A3 (en) | Carboxylic acid derivatives substituted by homo- or heterocyclic group preparation method and pharmaceutical compositions containing them | |
HK1030216A1 (en) | Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof | |
EP0811595A4 (en) | HYDROCHALCONE DERIVATIVES, COSMETIC COMPOSITIONS CONTAINING THEM AND PROCESSES FOR PREPARING SUCH DERIVATIVES OR COMPOSITIONS | |
HUP0103913A3 (en) | Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same | |
AU4949800A (en) | 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives | |
HUP0204157A3 (en) | 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same | |
HUP9900386A3 (en) | Use of phenoxy-pyridine derivatives for producing pharmaceutical compositions suitable for treating heart failure | |
HUP0002171A3 (en) | Aminophosphonic acid derivatives, method for their preparation and pharmaceutical compositions thereof | |
HUP0200816A3 (en) | Substituted 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases, process for their preparation and pharmaceutical compositions containing them | |
IL141165A0 (en) | New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same | |
EP1411056A3 (en) | Imidazo[1,2-a]pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for their preparation | |
IL190120A0 (en) | PREPARATION OF 9-AMINO OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a//1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES | |
HUP0103004A3 (en) | Substituted imidazo[1,2a]azines as selective inhibitors of cox-2, process for their preparation and pharmaceutical compositions containing them | |
HUP0105054A3 (en) | Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation | |
PL352280A1 (en) | Derivatives of naphthyridine, method of making same, use of same and pharmaceutical compositions containing these derivatives | |
HUP0202988A3 (en) | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them | |
PL328123A1 (en) | Derivatives of banzo[c]quinolysine and method of obtaining them | |
AU5101798A (en) | Method for oral administration of buspirone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |